Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intraductal Carcinoma and Lobular Carcinoma in Situ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00794989
What this trial is testing

Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer

Who this might be right for
Breast CancerPrecancerous Condition
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00952731
What this trial is testing

4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ

Who this might be right for
Ductal Breast Carcinoma in SituEstrogen Receptor-positive Breast Cancer
Northwestern University 27
Testing effectiveness (Phase 2)Ended earlyNCT03979508
What this trial is testing

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+15 more
Mayo Clinic 26
Not applicableStudy completedNCT02248662
What this trial is testing

Impact of Radiation Therapy on Breast Conservation in DCIS

Who this might be right for
DCIS
Dana-Farber Cancer Institute 3,436
Not applicableStudy completedNCT04170920
What this trial is testing

Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs

Who this might be right for
Breast CancerDCIS
Indiana University 62
Large-scale testing (Phase 3)UnknownNCT04046159
What this trial is testing

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

Who this might be right for
Breast Ductal Carcinoma in Situ
National Taiwan University Hospital 810
Testing effectiveness (Phase 2)Study completedNCT01556243
What this trial is testing

Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 270
Not applicableStudy completedNCT00599989
What this trial is testing

Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer

Who this might be right for
Breast CancerLong-term Effects Secondary to Cancer Therapy in AdultsSkin Reactions Secondary to Radiation Therapy
Abramson Cancer Center at Penn Medicine 28
Testing effectiveness (Phase 2)Study completedNCT00256217
What this trial is testing

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

Who this might be right for
DCIS
Rita Sanghvi, Mehta 42
Not applicableStudy completedNCT01961531
What this trial is testing

BrUOG 291: Five Fraction Partial Breast Irradiation Using Non-invasive Image-guided Breast Brachytherapy (NIBB)

Who this might be right for
Breast Cancer
Brown University 40
Not applicableStudy completedNCT00749931
What this trial is testing

MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery

Who this might be right for
Breast Cancer
Dune Medical Devices 664
Large-scale testing (Phase 3)Study completedNCT00769379
What this trial is testing

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

Who this might be right for
Breast Ductal Carcinoma In Situ
National Cancer Institute (NCI) 2,014
Large-scale testing (Phase 3)Study completedNCT00026286
What this trial is testing

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

Who this might be right for
Breast CancerHot FlashesMenopausal Symptoms
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT00909909
What this trial is testing

Radiation Therapy in Treating Women With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey 200
Large-scale testing (Phase 3)Looking for participantsNCT01185132
What this trial is testing

Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

Who this might be right for
Breast Cancer
Rocky Mountain Cancer Centers 660
Testing effectiveness (Phase 2)Ended earlyNCT02127073
What this trial is testing

Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Montefiore Medical Center 8
Not applicableStudy completedNCT04365114
What this trial is testing

Patient Outcomes from Second Film-readers and Test Threshold Relaxation in Breast Screening

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
University of Warwick 13,094,122
Early research (Phase 1)Study completedNCT00005886
What this trial is testing

Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
University of Kansas Medical Center
Not applicableStudy completedNCT00602628
What this trial is testing

Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 60
Not applicableStudy completedNCT02766881
What this trial is testing

Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS

Who this might be right for
DCIS
Ontario Clinical Oncology Group (OCOG) 281
Next Page